Interaction of Nanoparticles with Cells

被引:477
作者
Mailaender, Volker [1 ,2 ,3 ]
Landfester, Katharina [1 ,4 ]
机构
[1] Max Planck Inst Polymer Res, D-55128 Mainz, Germany
[2] Johannes Gutenberg Univ Mainz, Univ Med, Med Clin 3, D-55131 Mainz, Germany
[3] Univ Ulm, Dept Transfus Med, Inst Clin Transfus Med & Immunogenet Ulm, D-89081 Ulm, Germany
[4] Univ Ulm, Inst Organ Chem Macromol Chem & Organ Mat 3, D-89081 Ulm, Germany
关键词
SUPERPARAMAGNETIC IRON-OXIDE; MESENCHYMAL STEM-CELLS; POLY(BUTYL CYANOACRYLATE) NANOPARTICLES; POLYSTYRENE LATEX-PARTICLES; IN-VITRO DEGRADATION; MR CONTRAST AGENTS; MAGNETIC-RESONANCE; DRUG-DELIVERY; SIZE DISTRIBUTION; CELLULAR UPTAKE;
D O I
10.1021/bm900266r
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nanoparticles and their interaction with human cells have been a focus of many groups during the past decade. We discuss and review here the progress in the field of understanding and harnessing the interactions of polymeric nanoparticles synthesized by the miniemulsion process with different cell types. Nanotechnology and the hereby produced nanomaterials have promised to make use of specific properties of supramolecular assemblies and nanomaterials so that hitherto inaccessible effects can be exploited for new applications. Examples are superparamagnetism or the high surface area helpful for catalysis and adsorption. In biology and medicine, superparamagnetic iron oxide nanoparticles have been used for cell selection and as magnetic resonance imaging (MRI) contrast agents. Furthermore, uptake of nanoparticles into a wide variety of cells is an effect that seems to be specific for materials in the range of 50-200 nm. Surface modifications (positively or negatively charged side groups of the polymers, amino acids, or peptides/proteins) enhance this uptake. Knowledge about factors influencing cellular uptake, like size, surface properties, cell type, and endocytotic pathways, enables optimization of labeling and selection of cells and nanoparticles for applications in vitro and in vivo. For in vivo applications, we will focus on how nanoparticles can cross the blood-brain barrier.
引用
收藏
页码:2379 / 2400
页数:22
相关论文
共 169 条
[1]  
Abou-Montet K, 2005, MOL IMAGING, V4, P165
[2]  
Aime S, 2002, ANGEW CHEM INT EDIT, V41, P1017, DOI 10.1002/1521-3773(20020315)41:6<1017::AID-ANIE1017>3.0.CO
[3]  
2-P
[4]   Enhancement of topical delivery from biodegradable nanoparticles [J].
Alvarez-Román, R ;
Naik, A ;
Kalia, YN ;
Guy, RH ;
Fessi, H .
PHARMACEUTICAL RESEARCH, 2004, 21 (10) :1818-1825
[5]   Skin penetration and distribution of polymeric nanoparticles [J].
Alvarez-Román, R ;
Naik, A ;
Kalia, Y ;
Guy, RH ;
Fessi, H .
JOURNAL OF CONTROLLED RELEASE, 2004, 99 (01) :53-62
[6]  
ALYAUTDIN R, 1995, EUR J PHARM BIOPHARM, V41, P44
[7]   Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model [J].
Ambruosi, Alessandra ;
Gelperina, Svetlana ;
Khalansky, Alexander ;
Tanski, Sandra ;
Theisen, Alf ;
Kreuter, Joerg .
JOURNAL OF MICROENCAPSULATION, 2006, 23 (05) :582-592
[8]   The caveolae membrane system [J].
Anderson, RGW .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :199-225
[9]  
[Anonymous], 2017, Molecular Biology of the Cell
[10]  
Arbab Ali Syed, 2004, Mol Imaging, V3, P24, DOI 10.1162/153535004773861697